BDBM50291584 CHEMBL4160696

SMILES COc1cc2CCC(CC3C=CN(Cc4ccccc4)C=C3C(C)=O)C(=O)c2cc1OC

InChI Key InChIKey=HMFPNGCVUHYYTQ-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50291584   

TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50: 173nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/30/2020
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50: 286nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/30/2020
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50: 415nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/30/2020
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50: 415nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/30/2020
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50: 1.67E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/30/2020
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50: 3.97E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/30/2020
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50: 3.97E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/30/2020
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50: 3.97E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/30/2020
Entry Details Article
PubMed